Current therapies for chronic hepatitis C. - Wikidata - wikimedia - TriplyDB

Current therapies for chronic hepatitis C.

Current therapies for chronic hepatitis C.

http://www.wikidata.org/entity/Q37823576

about

Multiplexed quantification of nucleic acids with large dynamic range using multivolume digital RT-PCR on a rotational SlipChip tested with HIV and hepatitis C viral load Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics.

P2860

Q35551793-DBD86319-C7AA-4549-BC4D-13B3305886F3 Q40730284-311CF2BC-4742-4941-A86C-7B30C9127C1D

P2860

Current therapies for chronic hepatitis C.

http://www.wikidata.org/entity/Q37823576

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current therapies for chronic hepatitis C.

@en

Current therapies for chronic hepatitis C.

@nl

type

label

Current therapies for chronic hepatitis C.

@en

Current therapies for chronic hepatitis C.

@nl

prefLabel

Current therapies for chronic hepatitis C.

@en

Current therapies for chronic hepatitis C.

@nl

P1433

Q37823576-E8E8FDD1-1D6C-439E-84AE-730CDCD03BF4

P1476

Q37823576-7D6FCC9C-F708-4AC5-8104-193B695F5F6A

P2093

Q37823576-9EAC7511-F1D9-404B-908D-4F15C4EA41F7

P2860

Q37823576-03E4B644-24CC-4B3E-9826-4316A40C053B

Q37823576-0A425E1E-E7E0-450D-BE00-A591CE9324DB

Q37823576-0EEBEFAD-CA64-45E2-B527-1CB4AAD7ACE5

Q37823576-144E1B06-B165-421B-BB74-E20051F980A0

Q37823576-17C0D613-5CE5-4F98-BFDB-394098D53C6F

Q37823576-184DB83D-7324-41D1-AB5A-F862572EDB28

Q37823576-19183DB9-4978-41F7-9898-612CF970E34B

Q37823576-1C6EE40D-D3D9-4ECC-ABEB-EE275444FFC3

Q37823576-1D1157EF-0BD7-482A-820E-54622C6F8869

Q37823576-20FE5190-693E-4967-B390-DC145B51EEDD

P304

Q37823576-31EFBA87-EC15-4F91-9BF8-A96327863A02

P31

Q37823576-5b1efc2d-f12f-4bfa-a052-06c5e371c9ce

Q37823576-EADA7CE3-5BEB-48B6-B414-11E271AC5AB9

P356

Q37823576-293C155F-85EF-464F-BB65-6B5107E2EF7C

P407

Q37823576-D7C67355-5876-461E-A94A-BA87478B63EB

P433

Q37823576-1F86D5A4-0E80-4553-8A8D-470113F6A848

P478

Q37823576-EEB0E665-1C2F-46DF-9BC3-32A7FE43D75F

P577

Q37823576-CE0DA061-A56D-4C07-9080-6B2C2A1557C0

P698

Q37823576-8985CA10-3ECA-4EBE-8F34-D0FDD3465B58

P356

P1433

Pharmacotherapy

P1476

Current therapies for chronic hepatitis C.

@en

P2093

McKenzie C Ferguson

http://www.w3.org/2001/XMLSchema#string

P2860

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Acute hepatitis C virus infection: A chronic problem

Interferon for Hepatitis C Virus in Hemodialysis--an Individual Patient Meta-analysis of Factors Associated with Sustained Virological Response

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Diagnosis, management, and treatment of hepatitis C: an update

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study.

Telaprevir for previously treated chronic HCV infection.

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

P304

92-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.31.1.92

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21182362

http://www.w3.org/2001/XMLSchema#string